GSTM1 and chronic kidney disease: To avoid biased positive results, normalization of PLT count, LDH levels, Hb levels, and improvement in eGFR and CKD, each separately, included children whose analyzed parameter was abnormal prior to eculizumab initiation, and for whom effectiveness of the drug was expected.